1368
b i o c h e m i c a l p h a r m a c o l o g y 7 1 ( 2 0 0 6 ) 1 3 5 8 – 1 3 6 9
[
[
[
4] Bain RR, Jordan VC. Identification of a new metabolite of
tamoxifen in patient serum during breast cancer therapy.
Biochem Pharmacol 1983;32:373–5.
5] Kemp JV, Adam HK, Wakeling AE, Slater R. Identification
and biological activity of tamoxifen metabolites in human
serum. Biochem Pharmacol 1983;32:2045–52.
6] Lien EA, Solheim E, Kvinnsland S, Ueland PM. Identification
of 4-hydroxy-N-desmethyltamoxifen as a metabolite
of tamoxifen in human bile. Cancer Res
microsomes and the pore-forming peptide alamethicin.
Drug Metab Dispos 2000;28:560–6.
[21] Hawes EM. N -glucuronidation, a common pathway in
human metabolism of drugs with a tertiary amine group.
Drug Metab Dispos 1998;26:830–7.
[22] Luo H, Hawes EM, McKay G, Korchinski ED, Midha KK. N -
+
+
glucuronidation of aliphatic tertiary amines, a general
phenomenon in the metabolism of H
humans. Xenobiotica 1991;21:1281–8.
1
-antihistamines in
1
988;48:2304–8.
[23] Breyer-Pfaff U, Mey U, Green MD, Tephly TR. Comparative
N-glucuronidation kinetics of ketotifen and amitriptyline
by expressed human UDP-glucuronosyltransferases and
liver microsomes. Drug Metab Dispos 2000;28:869–72.
[24] Ritter JK, Chen F, Sheen YY, Tran HM, Kimura S, Yeatman
MT, et al. A novel complex locus UGT1 encodes human
bilirubin, phenol, and other UDP-glucuronosyltransferase
isozymes with identical carboxyl termini. J Biol Chem
1992;267:3257–61.
[25] Ebner T, Remmel RP, Burchell B. Human bilirubin UDP-
glucuronosyltransferase catalyzes the glucuronidation of
ethinylestradiol. Mol Pharmacol 1993;43:649–54.
[26] Mojarrabi B, Butler R, Mackenzie PI. cDNA cloning and
characterization of the human UDP
[
[
7] Poon GK, Chui YC, McCague R, Lønning PE, Feng R,
Rowlands MG, et al. Analysis of phase I and phase II
metabolites of tamoxifen in breast cancer patients. Drug
Metab Dispos 1993;21:1119–24.
8] Katzenellenbogen BS, Norman MJ, Eckert RL, Peltz SW,
Mangel WF. Bioactivities, estrogen receptor interactions,
and plasminogen activator-inducing activities of tamoxifen
and hydroxy-tamoxifen isomers in MCF-7 human breast
cancer cells. Cancer Res 1984;44:112–9.
9] Williams ML, Lennard MS, Martin IJ, Tucker GT.
Interindividual variation in the isomerization of 4-
hydroxytamoxifen by human liver microsomes:
involvement of cytochromes P450. Carcinogenesis
[
1
994;15:2733–8.
glucuronosyltransferase, UGT1A3. Biochem Biophys Res
Commun 1996;225:785–90.
[27] Harding D, Fournel-Gigleux S, Jackson MR, Burchell B.
Cloning and substrate specificity of a human phenol UDP-
glucuronosyltransferase expressed in COS-7 cells. Proc Natl
Acad Sci USA 1988;85:8381–5.
[28] Strassburg CP, Oldhafer K, Manns MP, Tukey RH.
Differential expression of the UGT1A locus in human liver,
biliary, and gastric tissue: identification of UGT1A7 and
UGT1A10 transcripts in extrahepatic tissue. Mol Pharmacol
1997;52:212–20.
[29] Strassburg CP, Manns MP, Tukey RH. Expression of the
UDP-glucuronosyltransferase 1A locus in human colon. J
Biol Chem 1998;273(15):8719–26.
[
[
10] Nishiyama T, Ogura K, Nakano H, Ohnuma T, Kaku T,
Hiratsuka A, et al. Reverse geometrical selectivity in
glucuronidation and sulfation of cis- and trans-4-
hydroxytamoxifens by human liver UDP-
glucuronosyltransferases and sulfotransferases. Biochem
Pharmacol 2002;63:1817–30.
11] Lien EA, Solheim E, Lea OA, Lundgren S, Kvinnsland S,
Ueland PM. Distribution of 4-hydroxy-N-
desmethyltamoxifen and other tamoxifen metabolites in
human biological fluids during tamoxifen treatment.
Cancer Res 1989;49:2175–83.
[
[
12] Fromson JM, Pearson S, Bramah S. The metabolism of
tamoxifen (I.C.I.46,474). II. In female patients. Xenobiotica
1
973;3:711–4.
[30] Wooster R, Sutherland L, Ebner T, Clarke D, Da Cruze Silva
O, Burchell B. Cloning and stable expression of a new
member of the human liver phenol/bilirubin: UDP-
glucuronosyltransferase cDNA family. Biochem J
1991;278:465–9.
13] Kaku T, Ogura K, Nishiyama T, Ohnuma T, Muro K,
Hiratsuka A. Quaternary ammonium-linked
glucuronidation of tamoxifen by human liver microsomes
and UDP-glucuronosyltransferase 1A4. Biochem Pharmacol
2
004;67:2093–102.
[31] Fournel-Gigleux S, Jackson MR, Wooster R, Burchell B.
Expression of a human liver cDNA encoding a UDP-
glucuronosyltransferase catalysing the glucuronidation of
hyodeoxycholic acid in cell culture. FEBS Lett 1989;243:
119–22.
[
[
[
14] McCague R, Parr IB, Leclercq G, Leung OT, Jarman M.
Metabolism of tamoxifen by isolated rat hepatocytes.
Identification of the glucuronide of 4-hydroxytamoxifen.
Biochem Pharmacol 1990;39:1459–65.
15] Robertson DW, Katzenellenbogen JA. Synthesis of the E and
Z isomers of the antiestrogen tamoxifen and its metabolite,
hydroxytamoxifen, in tritium-labeled form. J Org Chem
[32] Ritter JK, Chen F, Sheen YY, Lubet RA, Owens IS. Two
human liver cDNAs encode UDP-glucuronosyltransferases
with 2 log differences in activity toward parallel substrates
including hyodeoxycholic acid and certain estrogen
derivatives. Biochemistry 1992;31:3409–14.
[33] Jin C-J, Miners JO, Lilywhite KJ, Mackenzie PI. cDNA cloning
and expression of two new members of the human liver
UDP-glucuronosyltransferase 2B subfamily. Biochem
Biophys Res Commun 1993;194:496–503.
[34] Ritter JK, Sheen YY, Owens IS. Cloning and expression of
human liver UDP-glucuronosyltransferase in COS-1 cells.
3,4-catechol estrogens and estriol as primary substrates. J
Biol Chem 1990;265:7900–6.
[35] Jin C-J, Miners JO, Lilywhite KJ, Mackenzie PI.
Complementary deoxyribonucleic acid cloning and
expression of a human liver uridine diphosphate-
glucuronosyltransferase glucuronidating carboxylic
acid-containing drugs. J Pharmcol Exp Ther
1
982;47:2387–93.
16] Katzenellenbogen JA, Carlson KE, Katzenellenbogen BS.
Facile geometric isomerization of phenolic non-steroidal
estrogens and antiestrogens: limitations to the
interpretation of experiments characterizing the activity of
individual isomers. J Steroid Biochem 1985;22:589–96.
17] Foster AB, Jarman M, McCague R, Leclercq G,
Devleeschouwer N. Hydroxy derivatives of tamoxifen. J
Med Chem 1985;28:1491–7.
18] Strassburg CP, Manns MP, Tukey RH. Differential down-
regulation of the UDP-glucuronosyltransferase 1A locus is
an early event in human liver and biliary cancer. Cancer
Res 1997;57:2979–85.
[
[
[
[
19] Bradford MM. A rapid and sensitive method for the
quantitation of microgram quantities of protein utilizing
the principle of protein-dye binding. Anal Biochem
1993;264:475–9.
1
976;72:248–54.
[36] Coffman BL, Rios GR, King CD, Tephly TR. Human UGT2B7
catalyzes morphine glucuronidation. Drug Metab Dispos
1997;25:1–4.
20] Fisher MB, Campanale K, Ackermann BL, VandenBranden
M, Wrighton SA. In vitro glucuronidation using human liver